BioSpace News Archive

SpyBiotech, a company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases, announces that its partner the Serum Institute of India has dosed the first subjects in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19.

KAIST GSI forum explores big questions in the medical and bio-engineering revolution caused by the COVID-19 in fight against infectious diseases and life quality

Quotient Limited, headquartered in Eysins, Switzerland, announced that the Company and Ortho Clinical Diagnostics have signed a binding letter of intent that confirms the termination of their former distribution agreement and related contracts and resolves all their disputes over the former distribution agreement.

NovaBay® Pharmaceuticals, Inc. announces the availability of “subscribe & save” for repeat orders of Avenova® antimicrobial lid & lash solution on Avenova.com and Amazon.com.

Aravive, Inc., a clinical-stage oncology company developing transformative therapeutics, announced that the Company will present and conduct one-on-one meetings at the following two virtual investor conferences in September

Sol-Gel Technologies, a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, announced that the company will present at the following upcoming virtual investor conferences.

BioCryst Pharmaceuticals, Inc. announced that the company will present at the 22nd annual H.C. Wainwright Global Investment Conference on Monday, September 14, 2020 at 9:30 a.m. ET.

Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with Hall of Famer and baseball’s all-time “Iron Man”, Cal Ripken Jr. This year marks 25 years since Ripken played in his 2,131st consecutive game, eclipsing the thought to be unbreakable record of 2,130 set by the legendary Lou Gehrig.

Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the Morgan Stanley Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 2:00 p.m. Eastern Time.